These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19699018)

  • 1. Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis.
    Raj DS; Shah VO; Rambod M; Kovesdy CP; Kalantar-Zadeh K
    Am J Kidney Dis; 2009 Dec; 54(6):1062-71. PubMed ID: 19699018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.
    Raj DS; Carrero JJ; Shah VO; Qureshi AR; Bárány P; Heimbürger O; Lindholm B; Ferguson J; Moseley PL; Stenvinkel P
    Am J Kidney Dis; 2009 Dec; 54(6):1072-80. PubMed ID: 19733948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients.
    Feroze U; Kalantar-Zadeh K; Sterling KA; Molnar MZ; Noori N; Benner D; Shah V; Dwivedi R; Becker K; Kovesdy CP; Raj DS
    J Ren Nutr; 2012 May; 22(3):317-26. PubMed ID: 21880509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.
    Navarro-González JF; Mora-Fernández C; Muros de Fuentes M; Donate-Correa J; Cazaña-Pérez V; García-Pérez J
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2272-9. PubMed ID: 21784820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study.
    Rambod M; Bross R; Zitterkoph J; Benner D; Pithia J; Colman S; Kovesdy CP; Kopple JD; Kalantar-Zadeh K
    Am J Kidney Dis; 2009 Feb; 53(2):298-309. PubMed ID: 19070949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Lipopolysaccharide-Binding Protein is Associated with Chronic Inflammation and Metabolic Syndrome in Hemodialysis Patients.
    Lim PS; Chang YK; Wu TK
    Blood Purif; 2019; 47(1-3):28-36. PubMed ID: 30219816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
    Poesen R; Ramezani A; Claes K; Augustijns P; Kuypers D; Barrows IR; Muralidharan J; Evenepoel P; Meijers B; Raj DS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1525-33. PubMed ID: 26153127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.
    Kalantar-Zadeh K; McAllister CJ; Lehn RS; Lee GH; Nissenson AR; Kopple JD
    Am J Kidney Dis; 2003 Oct; 42(4):761-73. PubMed ID: 14520627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients.
    Kalantar-Zadeh K; Kopple JD; Humphreys MH; Block G
    Nephrol Dial Transplant; 2004 Jun; 19(6):1507-19. PubMed ID: 15069177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
    Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
    Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of metabolic disturbances and malnutrition-inflammation on 6-year mortality in Japanese patients undergoing hemodialysis.
    Nakagawa N; Matsuki M; Yao N; Hirayama T; Ishida H; Kikuchi K; Hasebe N
    Ther Apher Dial; 2015 Feb; 19(1):30-9. PubMed ID: 25196142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between Soluble CD14 Levels, Inflammation, Subclinical Atherosclerosis and Mortality in Hemodialysis Patients.
    Abdallah AM; Elhakeem H; Yahia MB; Youssef EMI; El-Khouly N; Elmohaseb GF; Awad EA; Hassan MM; Ghamry EM; Abdelhamed MR; Kotb E; Mahmoud TM
    Endocr Metab Immune Disord Drug Targets; 2023; 23(6):843-849. PubMed ID: 36221874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients.
    Carrero JJ; Nakashima A; Qureshi AR; Lindholm B; Heimbürger O; Bárány P; Stenvinkel P
    Kidney Int; 2011 Apr; 79(7):749-56. PubMed ID: 21178976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
    Drechsler C; Hayek SS; Wei C; Sever S; Genser B; Krane V; Meinitzer A; März W; Wanner C; Reiser J
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1265-1273. PubMed ID: 28495863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study.
    Lacson E; Wang W; Ma L; Passlick-Deetjen J
    Am J Kidney Dis; 2015 Dec; 66(6):1056-66. PubMed ID: 26190226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.
    Lakatos PL; Kiss LS; Palatka K; Altorjay I; Antal-Szalmas P; Palyu E; Udvardy M; Molnar T; Farkas K; Veres G; Harsfalvi J; Papp J; Papp M
    Inflamm Bowel Dis; 2011 Mar; 17(3):767-77. PubMed ID: 20865702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interdialytic creatinine change versus predialysis creatinine as indicators of nutritional status in maintenance hemodialysis.
    Walther CP; Carter CW; Low CL; Williams P; Rifkin DE; Steiner RW; Ix JH
    Nephrol Dial Transplant; 2012 Feb; 27(2):771-6. PubMed ID: 21775764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive role of serum calprotectin on mortality in hemodialysis patients with high phosphoremia.
    Kanki T; Kuwabara T; Morinaga J; Fukami H; Umemoto S; Fujimoto D; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Tajiri S; Tajiri T; Kitamura K; Mukoyama M
    BMC Nephrol; 2020 May; 21(1):158. PubMed ID: 32366231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.